Non-ST Elevation Myocardial Infarction (NSTEMI) – A Case Study
DOI:
https://doi.org/10.21276/aw4fhp10Keywords:
NSTEMI, Acute myocardial ischemia, Acute coronary syndrome, Non- atherosclerosis, Polycythemia veraAbstract
Polycythemia vera (PV) is a chronic myeloproliferative disorder characterized by a high risk of developing arterial and venous thromboembolic complications. In recent years, great insight has been gained into the understanding of the pathogenesis of thrombosis in PV. Diagnosing and managing a case of acute coronary syndrome (ACS) due to non-atherosclerotic causes is a challenge. In this case report, we share our experience in diagnosis, management and revascularization issues in non-ST-elevation myocardial infarction (NSTEMI) in a patient with polycythemia vera background.
Downloads
References
Kumar A, Cannon CH. Acute coronary syndromes: Diagnosis and management, Part I. Mayo Clin Proc. 2009;84(10):917-938.
Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999-3054.
de Winter RJ, Tijssen JGP. Non–ST–segment elevation myocardial infarction revascularization for everyone? JACC: Cardiovascular Interventions. 2012;5(9):903-905. DOI: 10.1016/j.jcin.2012.07.001
Van Horn SE Jr, Manju CV. Management of non–ST–segment elevation myocardial infarction. Medical Clinics of North America. 2007;91(4):683-700.
Benjamin D, Yeshurun D, Charnilas J, Pinkhas J. Hyperlipidemia and myocardial infarction among 118 patients with polycythemia vera. Am J Med Sci. 1978;276:23-26.
Cheitlin MD, McAllister HA, de Castro CM. Myocardial infarction without atherosclerosis. The Journal of the American Medical Association. 1975;231:951-959.
Bob-Manuel T, Ifedili I, Reed G, Ibebougu UN, Khozam RN. Non-ST elevation acute coronary syndromes: A comprehensive review. Current Problems in Cardiology. 2017;42(9): 266-305.
Dolai TK, Mandal PK. Non-ST-segment elevation myocardial infarction (NSTEMI) in a 43-year-old man – Uncommon etiology. Journal of Indian College of Cardiology. 2014;4:277-280.
Bahbahani H, Aljenaee K, Bella A. Polycythemia vera presenting as acute myocardial infarction: An unusual presentation. J Saudi Heart Assoc. 2015;27:57-60.
Hosoya H, Levine JJ, Henry DH, Goldberg S. Double the trouble: Acute coronary syndrome and ischemic stroke in polycythemia vera. The American Journal of Medicine. 2017;130(6):e237-e240.
Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood. 1984;64: 1-12.
Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocythemia: an interim report from the polycythemia vera study group. Semin Hematol. 1986;23:177-182.
Venegoni P, Schroth G. Myocardial infarction and polycythemia vera: How should we treat it? Cathet Cardiovasc Diagn. 1994;32:259-261.
Adel G, Aoulia D, Amina Y, Aymen BA, Abdel-Hamid NM Polycythemia vera and acute coronary syndromes: Pathogenesis, risk factors and treatment. Journal of Hematology and Thromboembolic Diseases. 2013;1:107. DOI: 10.4172/2329-8790.1000107
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
